Institute of Molecular Physical Science, Swiss Federal Institute of Technology, ETH-Hönggerberg, 8093 Zurich, Switzerland.
Department of Pharmaceutical Sciences, Faculty of Life Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.
Int J Mol Sci. 2023 Sep 20;24(18):14329. doi: 10.3390/ijms241814329.
Protein-fragment complex structures are particularly sought after in medicinal chemistry to rationally design lead molecules. These structures are usually derived using X-ray crystallography, but the failure rate is non-neglectable. NMR is a possible alternative for the calculation of weakly interacting complexes. Nevertheless, the time-consuming protein signal assignment step remains a barrier to its routine application. NMR Molecular Replacement (MR) is a versatile and rapid method that enables the elucidation of a protein-ligand complex structure. It has been successfully applied to peptides, drug-like molecules, and more recently to fragments. Due to the small size of the fragments, ca < 300 Da, solving the structures of the protein-fragment complexes is particularly challenging. Here, we present the expected performances of MR when applied to protein-fragment complexes. The MR approach has been benchmarked with the SERAPhic fragment library to identify the technical challenges in protein-fragment NMR structure calculation. A straightforward strategy is proposed to increase the method's success rate further. The presented work confirms that MR is an alternative method to X-ray crystallography for solving protein-fragment complex structures.
蛋白质片段复合物结构在药物化学中是特别需要的,以合理设计先导分子。这些结构通常使用 X 射线晶体学来推导,但失败率不容忽视。NMR 是计算弱相互作用复合物的一种可行替代方法。然而,耗时的蛋白质信号分配步骤仍然是其常规应用的障碍。NMR 分子置换 (MR) 是一种通用且快速的方法,可用于阐明蛋白质-配体复合物的结构。它已成功应用于肽、类药分子,最近还应用于片段。由于片段的尺寸较小,约 < 300 Da,因此解决蛋白质-片段复合物的结构特别具有挑战性。在这里,我们展示了将 MR 应用于蛋白质片段复合物时的预期性能。已经使用 SERAPhic 片段库对 MR 方法进行了基准测试,以确定蛋白质片段 NMR 结构计算中的技术挑战。提出了一种简单的策略来进一步提高方法的成功率。所提出的工作证实,MR 是解决蛋白质片段复合物结构的 X 射线晶体学的替代方法。